Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

the words "FDA recall" on a board

Abbott’s HeartMate LVADs recalled again over screen issues—FDA highlights significant risks

Abbott has received multiple reports of its HeartMate monitor screens freezing, glitching and even displaying incorrect patient information. A total of 17 injuries have been reported so far. 

Thumbnail

MRI safety concerns prompt FDA to issue recall for series of ventilators

The Class I recall affects the ZOLL 731 Series Ventilator family, including the AEV, EMV+, and Eagle II models.

scale money prices shopping transparency reimbursement dollar coins

CMS discounts dozens of drugs to thwart price hikes

Dozens of drugs are seeing price cuts that could save Medicare enrollees as much as $4,593 per day, CMS said.

pharmaceutical drug approval process

Biden Administration lowers prices for 64 prescription drugs, including 3 prescribed by cardiologists

The new list of discounted drugs includes an anticoagulant, a beta-blocker used to treat atrial fibrillation and much more. 

Thumbnail

Federal judge strikes down HHS ban on tracking cookies

Providers argued the HHS overstepped its regulatory authority. A federal court in Texas agreed.

Thumbnail

Research shows hospital mergers contribute to overdoses, suicides

A new paper from the National Bureau of Economic Research found the rise in care costs from mergers contributes to layoffs that have economic ripple effects.

Cardiologist heart

New editor shares vision for ACC’s flagship journal: ‘Chasing impact, not impact factor’

Veteran cardiologist Harlan M. Krumholz, MD, has a long history in medical research as both an author and an editor. He and his team want to review manuscripts quickly and publish a wide variety of voices.

tirzepatide injections Zepbound Eli Lilly

Diabetes drug resolves sleep apnea in up to 52% of patients—is FDA approval in the cards?

Based on positive results from two different trials, Eli Lilly and Company hopes to secure a new FDA approval for tirzepatide in the months ahead.